Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Red Cat | RCAT | Oct 30, 2024 | 3.17 | -3.35 |
Red River Bancshares | RRBI | Oct 30, 2024 | 52.96 | +0.46 |
Red Robin Gourmet Burgers | RRGB | Oct 30, 2024 | 6.04 | +1.17 |
Red Rock Resorts A | RRR | Oct 30, 2024 | 53.10 | -2.87 |
Red Violet | RDVT | Oct 30, 2024 | 30.07 | -0.76 |
RDDT | Oct 30, 2024 | 116.05 | +41.97 | |
Redfin | RDFN | Oct 30, 2024 | 10.32 | +6.28 |
RedHill Biopharma ADR | RDHL | Oct 30, 2024 | 8.34 | +4.12 |
Redwire | RDW | Oct 30, 2024 | 7.90 | -5.16 |
Redwood Trust | RWT-A | Oct 30, 2024 | 26.02 | +0.46 |
Redwood Trust | RWT | Oct 30, 2024 | 7.64 | +0.39 |
REE Automotive A | REE | Oct 30, 2024 | 7.37 | -4.29 |
Regal Rexnord | RRX | Oct 30, 2024 | 169.05 | -0.22 |
Regency Centers | REG | Oct 30, 2024 | 72.70 | +0.37 |
Regency Centers A Pref | REGCP | Oct 30, 2024 | 24.75 | 0.00 |
Regency Centers B Pref | REGCO | Oct 30, 2024 | 24.25 | 0.00 |
Regeneron Pharmaceuticals | REGN | Oct 30, 2024 | 922.79 | -0.49 |
REGENXBIO | RGNX | Oct 30, 2024 | 8.84 | -2.43 |
Regional Health Properties | RHE | Oct 30, 2024 | 1.80 | +0.56 |
Regional Health Properties A Pref | RHE-A | Oct 30, 2024 | 0.54 | 0.00 |
Regional Management | RM | Oct 30, 2024 | 28.96 | +0.03 |
Regions Financial | RF | Oct 30, 2024 | 24.06 | +0.80 |
Regions Financial B Pref | RF-B | Oct 30, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Oct 30, 2024 | 25.09 | +0.52 |
Regions Financial E Pref | RF-E | Oct 30, 2024 | 19.45 | +0.52 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Oct 30, 2024 | 25.91 | 0.00 |
Regis | RGS | Oct 30, 2024 | 24.36 | +2.22 |
Regulus Therapeutics | RGLS | Oct 30, 2024 | 1.56 | -3.11 |
Reinsurance Group of America | RGA | Oct 30, 2024 | 214.92 | +1.65 |
REIT Index ETF Vanguard | VNQ | Oct 30, 2024 | 95.77 | +0.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.